Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

ECO 2026 12 - 15 May 2026

Renal or Hepatic Impairment Does Not Affect the Pharmacokinetics, Safety or Tolerability of Subcutaneous Cagrilintide

Authors :

Mette J. F. Nielsen¹; Niels-Peter Becker¹; Helene H. Hansen Duus¹; Katrine Kirkeby¹; Viera Kupčová²; Britt W. Lauenborg¹; Benjamin Low¹; Olivia Svolgaard¹; Louise Witten¹

Affiliations

View Details Hide Details

Download .PDF

Keywords

Obesity

Congress poster

GLP-1 RA

Cagrilintide

Pre-clinical